Sign In
Buy MBRX
$0.400
-0.620 (-60.78%)
At Close: Jul 31, 2026
Why Is Moleculin Biotech (MBRX) Stock Is Moving Today?
08:24am, Friday, 15'th Sep 2023
Moleculin Biotech (NASDAQ: MBRX ) stock is on the move Friday after the clinical-stage pharmaceutical company provided an update to investors. According to a press release from Moleculin Biotech, the
Moleculin to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:35am, Tuesday, 05'th Sep 2023
HOUSTON , Sept. 5, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a growing pipeline, including Phase 2 clini
Moleculin Biotech, Inc. (MBRX) Q2 2023 Earnings Call Transcript
10:08am, Friday, 11'th Aug 2023
Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q2 2023 Earnings Call Transcript August 11, 2023 8:30 AM ET Company Participants Jenene Thomas - IR Walter Klemp - Chairman & CEO John Paul Waymack - Senior CMO
Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast
08:45am, Thursday, 03'rd Aug 2023
HOUSTON , Aug. 3, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeti
Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
08:35am, Tuesday, 13'th Jun 2023
Live webcast fireside chat on Wednesday, June 21 st at 1:30 PM ET HOUSTON , June 13, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmac
Moleculin Biotech, Inc. (MBRX) Q1 2023 Earnings Call Transcript
11:29am, Thursday, 11'th May 2023
Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Jenene Thomas - Investor Relations Walter Klemp - Chairman and Chief Executive Offi
MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates
08:04am, Thursday, 11'th May 2023
Moleculin Biotech (NASDAQ: MBRX ) reported first quarter results for 2023. Moleculin Biotech reported a loss per share of 28 cents.
Moleculin to Report First Quarter Financial Results on May 11, 2023 and Host Conference Call and Webcast
08:35am, Thursday, 04'th May 2023
HOUSTON , May 4, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targetin
Here's Why Moleculin Biotech, Inc. (MBRX) Looks Ripe for Bottom Fishing
11:25am, Monday, 24'th Apr 2023
Moleculin Biotech, Inc. (MBRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreem
Moleculin Biotech, Inc. (MBRX) Upgraded to Buy: What Does It Mean for the Stock?
01:45pm, Monday, 27'th Mar 2023
Moleculin Biotech, Inc. (MBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Moleculin to Present at the Oppenheimer 33rd Annual Healthcare Conference
08:35am, Monday, 13'th Mar 2023
Presentation with live video webcast on Tuesday, March 14 th at 12:40 PM ET HOUSTON , March 13, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (Moleculin or the Company), a clinical st
Moleculin to Present at the Virtual Investor 2023 Companies to Watch Event
08:45am, Thursday, 05'th Jan 2023
Live video webcast on Tuesday, January 17 th at 9:00 AM ET HOUSTON, Jan. 5, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceut
Celularity, Moleculin Biotech And 2 Other Penny Stocks Insiders Are Aggressively Buying
11:11am, Tuesday, 29'th Nov 2022 Benzinga
The Dow Jones closed lower by around 500 points on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
08:49am, Tuesday, 22'nd Nov 2022 Benzinga
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
NeuroOne Medical Techn
Moleculin Biotech, Inc. (MBRX) Q3 2022 Earnings Call Transcript
12:57pm, Saturday, 12'th Nov 2022
Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Walter Klemp – Chairman and Chief Executive Officer Jonathan Foster – Exec
